Delivery Order SPE2DB24D2217-SPE2DB25FJXDR

Award Date 6/23/25
Potential Completion Date 6/24/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 2.5 mg tablets, a medication used to treat and prevent blood clots. The contract has a ceiling value of $5,350.72 and is a firm fixed-price delivery order, with an ultimate completion date of April 30, 2025. The contract is not set aside for any specific type of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Eliquis 2.5 mg tablets, a medication used to treat and prevent blood clots. The contract has a ceiling value of $1,638.00 and is a firm fixed-price contract with an ultimate completion date of April 30, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract has a firm fixed price, with a ceiling value of $20,037.66, and an ultimate completion date of May 2, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp is the prime...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The award has a ceiling value of $44,962.52 and an ultimate completion date of April 18, 2025. The contract is not set aside and was awarded on April 17, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract has a ceiling value of $11,571.83 and is a firm fixed-price delivery order contract with a performance period through May 1, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of Eliquis 2.5 mg tablets, a blood-thinning medication, for $1,187.55. The delivery order is a firm fixed-price contract with a completion date of July 31, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract has a ceiling value of $31,835.29 and a period of performance ending on April 28, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 2.5 mg tablets, a medication used to reduce the risk of stroke and blood clots. The contract has a ceiling value of $1,474.20 and a period of performance through April 14, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 2.5 mg tablet 60s, a medication used to treat and prevent blood clots. The contract has a ceiling value of $10,603.32 and is a firm fixed-price contract with an ultimate completion date of April 29, 2025. This award is not a set-aside contract, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract has a ceiling value of $6,712.58 and a period of performance through April 17, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
  • SPE2DB24D2217
    Indefinite Delivery Contract
  • SPE2DB24D2217-SPE2DB25FJXDR
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 2.5 mg tablets, a medication used to treat and prevent blood clots. The contract has a ceiling value of $1,742.66 and is a firm fixed-price delivery order. The contract is not set aside and was awarded on June 23, 2025, with an ultimate completion date of June 24, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This delivery order is likely part of the larger IDC, enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 9/22/25, 9:48 AM